ALung and CytoAgents CEOs talk pandemic’s impact on funding, trials

Related Posts

26Aug

Grapefruit USA, Inc. Commences Production of Its Patented Disruptive Time Release Hourglass(TM) THC+CBD Delivery Cream

Grapefruit USA, Inc., a fully licensed California based cannabis company, is announcing today that it has commenced production of the... read more
11Jul

DOE funds 8 biomanufacturing projects

Today, the U.S. Department of Energy announced the selection of eight projects totaling over $5 million to conduct research and... read more
11Dec

Springfield teen thanks community for help in regaining vision

A Springfield boy hosted a thank you concert for the community who helped him raise funds for his eSight glasses.... read more
20Aug

From Defense To Offense: Pixability’s Duffy Flips CTV Suitability On Its Head

Matt Duffy of Pixability, a vendor of brand safety tooling for YouTube and other platforms, describes how the category is... read more
26Apr

David Zamarin Named Young Entrepreneur of the Year

The Small Business Administration (SBA) has named David Zamarin the 2022 Young Entrepreneur of the Year for Massachusetts and New... read more
27Sep

How FutureFuel.io is combating the student debt crisis

FutureFuel.io is combating the student debt crisis. CEO Laurel Taylor joins Yahoo Finance's Zack Guzman, Kristin Myers, and Wall Street... read more
30Dec

Sustained Acoustic Medicine Technology from ZetrOZ Systems Endorsed By American Athletes, Veterans and Workers

Professional athletes, military veterans and everyday workers are getting back in action more quickly thanks to ZetrOZ's Sustained Acoustic Medicine... read more
28Sep

Cloud-Storage Firm Wasabi Reaches $1.1 Billion Valuation

Wasabi Technologies Inc., a Boston-based cloud-storage startup, has reached unicorn status with its latest fundraising. Read more >> read more
15Feb

eSight headset provides gift of vision

Recently, Rachael Ray has given individuals with vision loss the ability to see their loved ones. While her cooking is... read more
14Sep

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc.... read more